AccuSite injectable gel consisting of 5-fluorouracil and the vasoconstrictor epinephrine in bovine collagen matrix data

MATX (Menlo Park, Calif.) reported Phase III results in 359 evaluable patients showing a complete response in 77 percent of the 1,926 lesions treated with the agent. No systemic side effects were noted.

On a per-patient basis, the response rate was 89 percent, with 61 percent of the patients having a complete clearing of warts during the three-month period vs. 5 percent in placebo-treated patients. ...